These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6819090)

  • 21. Studies on the biosynthesis of macrophage migration inhibitory factor in delayed hypersensitivity. I. Effects of inhibitors of nucleic acid and protein synthesis on the production of macrophage migration inhibitory factor.
    Mizoguchi Y; Yamamoto S; Morisawa S
    J Biochem; 1973 Mar; 73(3):467-74. PubMed ID: 4723891
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on endoreduplication. III. Endoreduplication induced by mitomycin C in PHA-stimulated tonsillar lymphocyte cultures.
    Takanari H; Izutsu K
    Mutat Res; 1983 Feb; 107(2):297-306. PubMed ID: 6408469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chloramphenicol on in vitro function of lymphocytes.
    DaMert GJ; Sohnle PG
    J Infect Dis; 1979 Feb; 139(2):220-4. PubMed ID: 438534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products.
    Greineder DK; Connorton KJ; David JR
    J Immunol; 1979 Dec; 123(6):2808-13. PubMed ID: 501090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of blastogenic factor by mitomycin-treated cells in mixed lymphocyte cultures.
    Hirschberg H; Rankin B; Thorsby E
    Transplantation; 1974 Mar; 17(3):323-5. PubMed ID: 4273400
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules.
    Postlethwaite AE; Smith GN; Mainardi CL; Seyer JM; Kang AH
    J Immunol; 1984 May; 132(5):2470-7. PubMed ID: 6609200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanisms of inhibitory effects of liver extract on lymphocyte proliferation: II. Inhibition of DNA, RNA, and protein synthesis and their relationship to the effects of metabolic inhibitors.
    Su HL; Huang MH; Yu CL; Han SH; Chiang BN; Wang SR
    Clin Exp Immunol; 1988 May; 72(2):228-32. PubMed ID: 2457463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 rather than lymphocyte-activating factor produced by activated human mononuclear cells stimulates increases in murine thymocyte cAMP.
    Oppenheim JJ; Koopman WJ; Wahl LM; Dougherty SF
    Cell Immunol; 1980 Jan; 49(1):64-73. PubMed ID: 6243256
    [No Abstract]   [Full Text] [Related]  

  • 29. Storage enhances chromosome damage after exposure of human leukocytes to mitomycin C.
    Evans HJ; Vijayalaxmi
    Nature; 1980 Mar; 284(5754):370-2. PubMed ID: 7360275
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulated human lymphocytes produce a soluble factor which inhibits fibroblast migration.
    Rola-Pleszczynski M; Lieu H; Hamel J; Lemaire I
    Cell Immunol; 1982 Nov; 74(1):104-10. PubMed ID: 7159935
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
    Braun DP; Harris JE
    Clin Immunol Immunopathol; 1981 Aug; 20(2):193-214. PubMed ID: 6455230
    [No Abstract]   [Full Text] [Related]  

  • 32. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cooperations in the mitogen-induced transformation of human blood lymphocytes in healthy persons and in Hodgkin's disease.
    Schlaak M; Schröder P; Wulff JC
    Adv Exp Med Biol; 1979; 114():401-5. PubMed ID: 313675
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation.
    Faist E; Kupper TS; Baker CC; Chaudry IH; Dwyer J; Baue AE
    Arch Surg; 1986 Sep; 121(9):1000-5. PubMed ID: 3741094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition or augmentation of PHA-induced lymphocyte transformation by factors of calculated lymphoblastoid cell lines.
    Pinto M; Mizrahi A
    Experientia; 1979 Apr; 35(4):544-6. PubMed ID: 312212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host immune factors regulating fibrosis.
    Wahl SM
    Ciba Found Symp; 1985; 114():175-95. PubMed ID: 3851721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphocyte subset modulation of hepatic fibroblast function in murine schistosomiasis.
    Mansour MM; el-Ghorab NM; Salah LA; Dunn MA; Woody JN
    Am J Trop Med Hyg; 1989 Oct; 41(4):454-9. PubMed ID: 2508503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.
    Vose BM; Moore M
    Int J Cancer; 1979 Nov; 24(5):579-85. PubMed ID: 160895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.